News from Roche at the EAN congress
Data Provide Insight into the Mode of Action of MAVENCLAD™ (Cladribine Tablets) in Patients with Relapsing MS
News from Merck at the EAN congress
Highlights from the EAN in Amsterdam
Read about the highlights from the recent European Academy of Neurology congress in Amsterdam
Zebinix® (eslicarbazepine acetate) Data Demonstrate No Significant Negative Consequences on Neurocognitive Function in Children with Focal Epilepsy
News on Zebinix in children with focal epilepsy from the EPNS
New Marketing Authorisation for Zebinix®
Press release on behalf of Bial and Eisai
Documentary: Andrew Lees – Mentored by a Madman
Watch our documentary about Professor Andrew Lees
COPAXONE® no longer contraindicated during pregnancy in the UK
Industry News from Teva Pharma
EC grants Marketing Authorisation for Zebinix® for the treatment of partial-onset seizures in children
Industry news from Bial and Eisai
Life After Encephalitis: Ross’s Story
Ross’s story: An excerpt from “Life after Encephalitis” by Dr Ava Easton.
